Kim, Sung Bae <br/><br/>
Safety Analysis of Adjuvant Chemotherapy with Docetaxel Administered with or without Anthracyclines to Early Stage Breast Cancer Patients: Combined Results from the Asia- Pacific Breast Initiatives I and II.  [electronic resource] 

 -  Asian Pacific journal of cancer prevention : APJCP  2016 
 - 697-702 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study 
<br/><br/><label>ISSN: </label>2476-762X 
<br/><br/><label>Standard No.: </label>10.7314/apjcp.2016.17.2.697  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Docetaxel<br/>Doxorubicin--administration & dosage<br/>Epirubicin--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Longitudinal Studies<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neoplasm Staging<br/>Prognosis<br/>Prospective Studies<br/>Safety<br/>Survival Rate<br/>Taxoids--administration & dosage<br/>Young Adult